12:00 AM
May 24, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Abelcet: Marketed

Researchers presented data showing a 17 percent mortality rate among 12 liver transplant patients with invasive aspergillosis treated with Abelcet compared to...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >